Literature DB >> 12358262

Use of complementary and alternative medicine in patients with liver disease.

Doris B Strader1, Bruce R Bacon, Karen L Lindsay, Douglas R La Brecque, Timothy Morgan, Elizabeth C Wright, Jeff Allen, M Farooq Khokar, Jay H Hoofnagle, Leonard B Seeff.   

Abstract

OBJECTIVES: Complementary and alternative medicine (CAM) is used by 42% of the U.S. population. Its use among patients with chronic liver disease has not been well defined. Toward that end, we surveyed patients in six geographically diverse liver disease clinics in the United States for use of CAM.
METHODS: Patients attending six liver disease clinics were polled via a common questionnaire regarding their use of CAM. Demographic information was obtained to identify predictors of CAM use. Statistical analysis included univariate and multivariate analysis using logistic regression.
RESULTS: A total of 989 patients completed the questionnaire. Of these, 389 (39%) admitted to using some form of CAM at least once during the preceding month; 21% admitted to using herbal preparations, and 13% used herbs to treat their liver disease. Five variables were found to be predictive of alternative therapy use: female sex, young age, level of education, annual income, and geographic location. In all, 74% of patients reported using CAM in addition to the medications prescribed by their physician, but 26% did not inform their physician of their CAM use.
CONCLUSIONS: CAM use is as common among patients visiting liver disease clinics in the United States as in the general population (39% vs 42%). Many patients are using herbs to treat their liver disease but are declining to discuss this use with their physician.

Entities:  

Mesh:

Year:  2002        PMID: 12358262     DOI: 10.1111/j.1572-0241.2002.05993.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  38 in total

Review 1.  Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.

Authors:  Lilian W Kibathi; SoHyun Bae; Scott R Penzak; Parag Kumar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

2.  Chiropractic practice in military and veterans health care: The state of the literature.

Authors:  Bart N Green; Claire D Johnson; Anthony J Lisi; John Tucker
Journal:  J Can Chiropr Assoc       Date:  2009-08

Review 3.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Herbal hepatotoxicity: a hidden epidemic.

Authors:  Anna Licata; Fabio Salvatore Macaluso; Antonio Craxì
Journal:  Intern Emerg Med       Date:  2012-04-04       Impact factor: 3.397

5.  Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.

Authors:  Douglas L Nguyen; Ke-Qin Hu
Journal:  N Am J Med Sci (Boston)       Date:  2014

6.  Complementary and Alternative Medicine Use in United States Adults With Liver Disease.

Authors:  Jacqueline B Henson; Cristal L Brown; Shein-Chung Chow; Andrew J Muir
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

7.  Complementary and alternative medicine use in chronic liver disease patients.

Authors:  Leah M Ferrucci; Beth P Bell; Kathy B Dhotre; M Michele Manos; Norah A Terrault; Atif Zaman; Rosemary C Murphy; Grace R Vanness; Ann R Thomas; Stephanie R Bialek; Mayur M Desai; Andre N Sofair
Journal:  J Clin Gastroenterol       Date:  2010-02       Impact factor: 3.062

8.  Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection.

Authors:  Chihiro Morishima; Margaret C Shuhart; Chia C Wang; Denise M Paschal; Minjun C Apodaca; Yanze Liu; Derek D Sloan; Tyler N Graf; Nicholas H Oberlies; David Y-W Lee; Keith R Jerome; Stephen J Polyak
Journal:  Gastroenterology       Date:  2009-09-24       Impact factor: 22.682

Review 9.  Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection.

Authors:  Stephen J Polyak; Peter Ferenci; Jean-Michel Pawlotsky
Journal:  Hepatology       Date:  2013-03       Impact factor: 17.425

10.  Use of complementary and alternative medicine: a survey in Turkish gastroenterology patients.

Authors:  Taylan Kav
Journal:  BMC Complement Altern Med       Date:  2009-10-26       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.